Results 201 to 210 of about 19,193 (244)

Clinical efficacy of transjugular intrahepatic portosystemic shunt in treating esophageal variceal bleeding in patients with liver cirrhosis. [PDF]

Pak J Med Sci
Zhao Q, Zi Q, Dong G, Lu Y, Zhang Y.
europepmc   +1 more source

Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt. [PDF]

Dig Dis Sci
Waidyaratne G, Jalil S, Liu A, Liyanarachchi S, Makary MS, Rikabi A, Acharya C, Mendiratta V, Peng J, Ma J, Mumtaz K.   +10 more
europepmc   +1 more source

Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound <i>vs</i> fluoroscopic guidance: A dual-institution retrospective comparative study. [PDF]

World J Hepatol
Hung ML, Jairam A, Carr M, Berman ZT, Taddonio M, Minocha J, Aryafar H, Mondschein JI, Soulen MC, Nadolski GJ, Redmond J.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transjugular Intrahepatic Portosystemic Shunt

Contemporary Diagnostic Radiology, 2022
Chronic liver disease is the 11th leading cause of mortality in the United States.1 Portal hypertension is a common endpoint for progressive liver disease, and can clinically manifest as refractory ascites, splenomegaly, and life-threatening esophageal and gastric variceal bleeding.
Michelle T. Martin, Wadih Chacra
semanticscholar   +4 more sources

Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.

Radiology, 2022
Background Sarcopenia is frequently found in patients with cirrhosis and is associated with liver dysfunction, cirrhosis-related complications, and poorer quality of life.
Jiacheng Liu, Jinqiang Ma, Chongtu Yang, Manman Chen, Qin Shi, Chen Zhou, Songjiang Huang, Yang Chen, Yingliang Wang, Tongqiang Li, B. Xiong   +10 more
semanticscholar   +1 more source

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Annals of Internal Medicine, 2021
BACKGROUND The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode in patients after transjugular intrahepatic portosystemic shunt (TIPS) has not ...
C. Bureau, D. Thabut, C. Jezequel, Isabelle Archambeaud, L. D’alteroche, S. Dharancy, P. Borentain, F. Oberti, A. Plessier, V. de Lédinghen, N. Ganne-Carrié, N. Carbonell, V. Rousseau, A. Sommet, J. Péron, J. Vinel   +15 more
semanticscholar   +1 more source

Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study

American Journal of Gastroenterology, 2021
INTRODUCTION: Current guidelines recommend anticoagulation as the mainstay of portal vein thrombosis (PVT) treatment in cirrhosis. However, because of the heterogeneity of PVT, anticoagulation alone does not always achieve satisfactory results.
Yong Lv, W. Bai, Kai Li, Zhengyu Wang, Wengang Guo, B. Luo, Jian-hong Wang, Qiuhe Wang, E. Wang, D. Xia, Xiaomei Li, Jie Yuan, N. Han, J. Niu, Z. Yin, D. Fan, G. Han   +16 more
semanticscholar   +1 more source

Transjugular Intrahepatic Portosystemic Shunt Reductions

Seminars in Interventional Radiology, 2023
AbstractTransjugular intrahepatic portosystemic shunts (TIPS) are effective in reducing the portosystemic gradient and relieving complications of portal hypertension. Despite optimal patient selection, TIPS placement can be limited due to worsening hepatic encephalopathy and liver failure. In these cases, TIPS reduction may be necessary.
Arthur, Joseph, Jorge, Lopera
openaire   +2 more sources

Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta‐analysis, and trial sequential analysis of randomized trials

Journal of Gastroenterology and Hepatology, 2021
A preemptive transjugular intrahepatic portosystemic shunt (p‐TIPSS) after acute variceal bleeding (AVB) is advocated. However, when compared with the current standard of care, the survival benefit of p‐TIPSS is questionable.
I. Hussain, Y. Wong, R. Lohan, Su Lin, Rahul Kumar   +4 more
semanticscholar   +1 more source

TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS

Annual Review of Medicine, 1995
▪ Abstract  Management of bleeding esophageal varices due to portal hypertension has traditionally relied on endoscopic sclerotherapy and operative intervention with placement of a portosystemic shunt. Although percutaneous decompression of portal hypertension was investigated 25 years ago, it was not clinically feasible until recently.
J, Skeens, C, Semba, M, Dake
openaire   +3 more sources